Advertisement

Topics

Bristol-Myers Squibb's Opdivo fails Phase III small-cell lung cancer study https://firstwordpharma.com/node/1596968?tsid=28®ion_id=6 …

10:40 EDT 12 Oct 2018 | FirstWord Pharma

Bristol-Myers Squibb's Opdivo fails Phase III small-cell lung cancer study https://firstwordpharma.com/node/1596968?tsid=28&region_id=6 …

Original Article: Bristol-Myers Squibb's Opdivo fails Phase III small-cell lung cancer study https://firstwordpharma.com/node/1596968?tsid=28®ion_id=6 …

NEXT ARTICLE

More From BioPortfolio on "Bristol-Myers Squibb's Opdivo fails Phase III small-cell lung cancer study https://firstwordpharma.com/node/1596968?tsid=28®ion_id=6 …"

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topics

The Top 100 Pharmaceutical Companies
Top 10 biotech and pharmaceutical companies worldwide based on market value in 2015 2015 ranking of the global top 10 biotech and pharmaceutical companies based on revenue (in billion U.S. dollars) Johnson & Johnson, U.S. 74...

Clincial Trials
In a clinical trial or interventional study, participants receive specific interventions according to the research plan or protocol created by the investigators. These interventions may be medical products, such as drugs or devices; procedures; or change...